Search tool

Displaying 1 - 10 of 28

Document library

Current European data collection on emergency department presentations with acute recreational drug toxicity: Gaps and national variations

The systematic collection of data on ED presentation of toxicity related to NPS and classical drugs in Europe is scarce and the collection of data is highly variable between different countries. Euro-DEN...

Molecular structure of MT-45

Molecular structure of MT-45

Molecular structure of 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine (MT-45).

Risk Assessment Report of a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)

This report presents the data and findings of the risk assessment on the new psychoactive substance, MT-45, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and...

Document library

Regulatory approaches to new psychoactive substances (NPS) in the European Union

An overview of regulatory approaches to new psychoactive substances (NPS) in the European Union.

Four new drugs to be placed under control

Today, EU Ministers adopted a European Commission proposal to control four new psychoactive substances currently raising health concerns in Europe. With today's decision, the substances MDPV, methoxetamine, AH-7921, and 25I-NBOMe will be...

Meeting on the risk assessment of the new psychoactive substance 4,4’-DMAR and MT-45

The extended Scientific Committee of the EMCDDA met on 16 September 2014 to examine the risk assessment by the EMCDDA on the substances 4,4’-DMAR and MT-45.

EMCDDA expert meeting

molecular structure

Molecular structure of 4,4′-DMAR

Molecular structure of 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (para-methyl-4-methylaminorex, 4,4′-DMAR).

EMCDDA–Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’)

In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45. The two organisations concluded that sufficient information had been accumulated to...

Document library

The new drug phenomenon

"Editorial and Perspective" on new psychoactive substances (NPS).

EMCDDA–Europol 2013 Annual Report on the implementation of Council Decision 2005/387/JHA

This report presents the key activities performed by the EMCDDA and Europol in 2013, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the...